Download Unicorn Signals App

By EquityPandit

Latest News

Strides Shasun gets USFDA approval for pain reliever

Strides Shasun has got the approval from the US health regulator for pain reliever drug ibuprofen.

Strides Shasun has said in a BSE filing that the product will be marketed by Strides Pharma Inc in the US market under its OTC brand Nuprin.

The company has said quoting IRi data that the US market for ibuprofen tablets USP 200mg is approximately USD 520 million.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction